메뉴 건너뛰기




Volumn 143, Issue 1, 2004, Pages 26-30

Hereditary Predisposition for Development of Breast and Ovarian Carcinoma;Hereditární Dispozice ke Vzniku Karcinomu Prsu a Ovaria

Author keywords

BRCA1; BRCA2; Breast cancer; Ovarian cancer

Indexed keywords

ATM PROTEIN; BRCA1 PROTEIN; BRCA2 PROTEIN; GONADORELIN DERIVATIVE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN MLH1; PROTEIN MSH2; PROTEIN P53; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN;

EID: 0842278725     PISSN: 00087335     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (4)

References (46)
  • 2
    • 0034145318 scopus 로고    scopus 로고
    • Major oncogenes and tumor supressor genes involved in epithelial ovarian cancer
    • Aunoble, B., Sanches, R., Didier, E., Bignon Y. J.: Major oncogenes and tumor supressor genes involved in epithelial ovarian cancer (review). Int. J. Oncol., 2000, 16, s. 567-576.
    • (2000) Int. J. Oncol. , vol.16 , pp. 567-576
    • Aunoble, B.1    Sanches, R.2    Didier, E.3    Bignon, Y.J.4
  • 4
    • 0030893779 scopus 로고    scopus 로고
    • Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2
    • Cancer Genetics Studies Consortium
    • Burke, W., Daly, M., Garber, J. et al.: Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. JAMA, 1997, 277, s. 997-1003.
    • (1997) JAMA , vol.277 , pp. 997-1003
    • Burke, W.1    Daly, M.2    Garber, J.3
  • 5
    • 0038036629 scopus 로고    scopus 로고
    • Doporučené zásady péče o nemocné s nádory prsu a vaječníků a zdravé osoby se zárodečnými mutacemi genů BRCA1 nebo BRCA2
    • Doporučené zásady péče o nemocné s nádory prsu a vaječníků a zdravé osoby se zárodečnými mutacemi genů BRCA1 nebo BRCA2. Klinická onkologie, 2003, 16, s. 28-34.
    • (2003) Klinická Onkologie , vol.16 , pp. 28-34
  • 6
    • 0033372904 scopus 로고    scopus 로고
    • BRCA 1/2 carriers and endocrine risk modifiers
    • Eeles, R., Kadouri, L.: BRCA 1/2 carriers and endocrine risk modifiers. Endocrine-Related Cancer, 1999, 6, s. 521-528.
    • (1999) Endocrine-Related Cancer , vol.6 , pp. 521-528
    • Eeles, R.1    Kadouri, L.2
  • 7
    • 0842291209 scopus 로고    scopus 로고
    • Genetic susceptibility testing for breast cancer: Implications for practitioners
    • Estrin, J. T., Fleetwood, J., Lipsky, M.: Genetic susceptibility testing for breast cancer: Implications for practitioners. J. C. O. M., 2000, 7, s. 81-90.
    • (2000) J. C. O. M. , vol.7 , pp. 81-90
    • Estrin, J.T.1    Fleetwood, J.2    Lipsky, M.3
  • 8
    • 0002857364 scopus 로고    scopus 로고
    • Inherited susceptibility to breast and ovarian cancer
    • Fackenthal, J. D., Olopade, O.I.: Inherited susceptibility to breast and ovarian cancer. Advances in Oncology, 2000, 16, s. 10-18.
    • (2000) Advances in Oncology , vol.16 , pp. 10-18
    • Fackenthal, J.D.1    Olopade, O.I.2
  • 9
    • 0032537990 scopus 로고    scopus 로고
    • Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
    • Fisher, B., Constantino, J. P., Wickerham, D. L. et al.: Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J. Natl. Cancer Inst., 1998, 90, s. 1371-1388.
    • (1998) J. Natl. Cancer Inst. , vol.90 , pp. 1371-1388
    • Fisher, B.1    Constantino, J.P.2    Wickerham, D.L.3
  • 10
    • 0028330276 scopus 로고
    • Risk of cancer in BRCA1-mutation carriers
    • Ford, D., Easton, D. F., Bishop, T. et al.: Risk of cancer in BRCA1-mutation carriers. Lancet, 1994, 343, s. 692-695.
    • (1994) Lancet , vol.343 , pp. 692-695
    • Ford, D.1    Easton, D.F.2    Bishop, T.3
  • 11
    • 0028826709 scopus 로고
    • Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence
    • Ford, D., Easton, D. F., Peto, J.: Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am. J. Hum. Genet., 1995, 57, s. 1457-1462.
    • (1995) Am. J. Hum. Genet. , vol.57 , pp. 1457-1462
    • Ford, D.1    Easton, D.F.2    Peto, J.3
  • 13
    • 0029785830 scopus 로고    scopus 로고
    • BRCA1 mutations in selected series of breast/ovarian cancer patients
    • Garvin, A. M., Spycher, M., Häner, M. et al.: BRCA1 mutations in selected series of breast/ovarian cancer patients. J. Med. Genet., 1996, 33, s. 721-725.
    • (1996) J. Med. Genet. , vol.33 , pp. 721-725
    • Garvin, A.M.1    Spycher, M.2    Häner, M.3
  • 14
    • 0031412306 scopus 로고    scopus 로고
    • Genetics of breast cancer
    • Greene, M. H.: Genetics of breast cancer. Mayo Clinic Proc., 1997, 72, s. 54-65.
    • (1997) Mayo Clinic Proc. , vol.72 , pp. 54-65
    • Greene, M.H.1
  • 16
    • 0025613812 scopus 로고
    • Linkage of early-onset familial breast cancer to chromosome 17q21
    • Hall, J. M., Lee, M. K., Newman, B. et al.: Linkage of early-onset familial breast cancer to chromosome 17q21. Science, 1990, 250, s. 1684-1689.
    • (1990) Science , vol.250 , pp. 1684-1689
    • Hall, J.M.1    Lee, M.K.2    Newman, B.3
  • 18
    • 26744468361 scopus 로고    scopus 로고
    • Strategies for primary prevention and early detection of breast cancer
    • Hartmann, L. C.: Strategies for primary prevention and early detection of breast cancer. J. Clin. Outcomes Manage, 6 (Suppl. 8), S14-S17.
    • J. Clin. Outcomes Manage , vol.6 , Issue.SUPPL. 8
    • Hartmann, L.C.1
  • 20
    • 0842269503 scopus 로고    scopus 로고
    • Rapid detection of BRCA1 mutations ba the protein truncation test
    • Hogervorst, F. B. L., Cornelis, R. S., Bout, M. et al.: Rapid detection of BRCA1 mutations ba the protein truncation test. Nat. Genet., 1996, 12, s. 295-302.
    • (1996) Nat. Genet. , vol.12 , pp. 295-302
    • Hogervorst, F.B.L.1    Cornelis, R.S.2    Bout, M.3
  • 21
    • 0842291205 scopus 로고
    • Growth retardation and tumour inhibition by BRCA1
    • Holt, J. T., Thompson, M. E., Szabo, C. et al.: Growth retardation and tumour inhibition by BRCA1. Nature Genetics, 1995, 10, s. 208 až 211.
    • (1995) Nature Genetics , vol.10 , pp. 208
    • Holt, J.T.1    Thompson, M.E.2    Szabo, C.3
  • 24
    • 0344952047 scopus 로고
    • Dědičný karcinom prsu a ovaria - Rizika a možnosti volby
    • King, C., Rowell, S., Love, S. M.: Dědičný karcinom prsu a ovaria - rizika a možnosti volby. JAMA-CS, 1993, 7, s. 537-542.
    • (1993) JAMA-CS , vol.7 , pp. 537-542
    • King, C.1    Rowell, S.2    Love, S.M.3
  • 25
    • 0030932869 scopus 로고    scopus 로고
    • Gatekeepers and caretakers
    • Kinzler, K., Vogelstein, B.: Gatekeepers and caretakers. Nature, 1997, 386, s. 761-763.
    • (1997) Nature , vol.386 , pp. 761-763
    • Kinzler, K.1    Vogelstein, B.2
  • 27
  • 28
    • 0033408342 scopus 로고    scopus 로고
    • Breast cancer genetics and managed care
    • Kutner, S. E.: Breast cancer genetics and managed care. Cancer Supplem., 1999, 86, s. 2570-2574.
    • (1999) Cancer Supplem. , vol.86 , pp. 2570-2574
    • Kutner, S.E.1
  • 30
    • 0028113345 scopus 로고
    • A strong candidate for the breast and ovarian cancer susceptibility gene, BRCA1
    • Miki, Y., Swensen, J., Shattuck-Eidens, D. et al.: A strong candidate for the breast and ovarian cancer susceptibility gene, BRCA1. Science, 1994, 266, s. 66-71.
    • (1994) Science , vol.266 , pp. 66-71
    • Miki, Y.1    Swensen, J.2    Shattuck-Eidens, D.3
  • 31
    • 0842269500 scopus 로고    scopus 로고
    • Praha, ÚZIS ČR, 278 s
    • Novotvary 1998 ČR. Praha, ÚZIS ČR, 2001, 278 s.
    • (2001) Novotvary 1998 ČR
  • 32
    • 0344090068 scopus 로고    scopus 로고
    • Mutační analýza genu BRCA1 v rodinách s dědičným výskytem karcinomu prsu a ovaria
    • Pohlreich, P., Stříbrná, J., Kleibl, Z. et al.: Mutační analýza genu BRCA1 v rodinách s dědičným výskytem karcinomu prsu a ovaria. Chem. Iisty, 2000, 94, s. 541-542.
    • (2000) Chem. Iisty , vol.94 , pp. 541-542
    • Pohlreich, P.1    Stříbrná, J.2    Kleibl, Z.3
  • 33
    • 0030695346 scopus 로고    scopus 로고
    • Genetic testing for cancer risk
    • Ponder, B.: Genetic testing for cancer risk. Science, 1997, 278, s. 1050 až 1054.
    • (1997) Science , vol.278 , pp. 1050
    • Ponder, B.1
  • 34
    • 9844228503 scopus 로고    scopus 로고
    • Identification of allellic losses in benign, borderline and invasive epithellial ovarian tumors and correlation with cllinical outcome
    • Saretzki, G., Hoffman, U., Röhlke, P. et al.: Identification of allellic losses in benign, borderline and invasive epithellial ovarian tumors and correlation with cllinical outcome. Cancer, 1997, 80, s. 1241-1248.
    • (1997) Cancer , vol.80 , pp. 1241-1248
    • Saretzki, G.1    Hoffman, U.2    Röhlke, P.3
  • 35
    • 0030965157 scopus 로고    scopus 로고
    • BRCA1 is a component of the RNA polymerase II holoenzyme
    • Scully, R., Anderson, S. F., Chao, D. M. et al.: BRCA1 is a component of the RNA polymerase II holoenzyme. Proc. Natl. Acad. Sci. USA, 1997, 94, s. 5605-5610.
    • (1997) Proc. Natl. Acad. Sci. USA , vol.94 , pp. 5605-5610
    • Scully, R.1    Anderson, S.F.2    Chao, D.M.3
  • 36
    • 0030852505 scopus 로고    scopus 로고
    • BRCA1 sequence analysis in women at high risk for susceptibility mutations
    • Shattuck-Eidens, D., Oliphant, A., McCure, M. et al.: BRCA1 sequence analysis in women at high risk for susceptibility mutations. JAMA, 1997, 278, s. 1242-1250.
    • (1997) JAMA , vol.278 , pp. 1242-1250
    • Shattuck-Eidens, D.1    Oliphant, A.2    McCure, M.3
  • 37
    • 8544224972 scopus 로고    scopus 로고
    • Genomic deletions in the BRCA1, BRCA2 and TP53 regions associate with low expression of the estrogen receptor in sporadic breast carcinoma
    • Schmutzler, R. K., Bierhof, E., Werkhausen, T. et al.: Genomic deletions in the BRCA1, BRCA2 and TP53 regions associate with low expression of the estrogen receptor in sporadic breast carcinoma. Int. J. Cancer, 1997, 74, s. 322-325.
    • (1997) Int. J. Cancer , vol.74 , pp. 322-325
    • Schmutzler, R.K.1    Bierhof, E.2    Werkhausen, T.3
  • 38
    • 0034594659 scopus 로고    scopus 로고
    • Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations
    • Schrag, D., Kuntz, K. M., Garber, J. E., Weeks, J. C.: Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations. JAMA, 2000, 283, s. 617-624.
    • (2000) JAMA , vol.283 , pp. 617-624
    • Schrag, D.1    Kuntz, K.M.2    Garber, J.E.3    Weeks, J.C.4
  • 39
    • 0030759895 scopus 로고    scopus 로고
    • Arrest of the cell cycle by the tumor-supressor BRCA1 requires the CDK-inhibition p21 (WAF1/CIP1)
    • Somasundaram, K., Zhang, H., Zeng, Y. X. et al.: Arrest of the cell cycle by the tumor-supressor BRCA1 requires the CDK-inhibition p21 (WAF1/CIP1). Nature, 1997, 389, s. 187-190.
    • (1997) Nature , vol.389 , pp. 187-190
    • Somasundaram, K.1    Zhang, H.2    Zeng, Y.X.3
  • 40
    • 0035404247 scopus 로고    scopus 로고
    • Risk of breast and ovarian cancer in women with strong family histories
    • Sristava, A., McKinnon, W., Wood, M.: Risk of breast and ovarian cancer in women with strong family histories. Oncology, 15, s. 889-902.
    • Oncology , vol.15 , pp. 889-902
    • Sristava, A.1    McKinnon, W.2    Wood, M.3
  • 41
    • 0029864134 scopus 로고    scopus 로고
    • Genetic testing for cancer susceptibility
    • Statement of the American Society of Clinical Oncology: Genetic testing for cancer susceptibility. J. Clin. Oncol., 1996, 14, s. 1730-1736.
    • (1996) J. Clin. Oncol. , vol.14 , pp. 1730-1736
  • 42
    • 0342940785 scopus 로고    scopus 로고
    • Pathology of familial breast cancer: Differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases
    • Stratton, M. R.: Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Lancet, 1997, 349, s. 1505-1509.
    • (1997) Lancet , vol.349 , pp. 1505-1509
    • Stratton, M.R.1
  • 43
    • 0344952045 scopus 로고    scopus 로고
    • Genetické faktory ovlivňující vývoj karcinomu prsu
    • Strnad, P.: Genetické faktory ovlivňující vývoj karcinomu prsu. Moderní gynekologie a porodnictví, 1998, 7, s. 36-45.
    • (1998) Moderní Gynekologie a Porodnictví , vol.7 , pp. 36-45
    • Strnad, P.1
  • 45
    • 0037169354 scopus 로고    scopus 로고
    • Cancer susceptibility and the functions of BRCA1 and BRCA2
    • Venkitaraman, A. R.: Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell, 2002, 108, s. 171-182.
    • (2002) Cell , vol.108 , pp. 171-182
    • Venkitaraman, A.R.1
  • 46
    • 0345383555 scopus 로고    scopus 로고
    • Analyza mutací genu BRCA1 u skupiny rizikových pacientek s karcinomem ovaria
    • Zikán, M., Pohlreich, P., Stříbrná, J., Jančárková, N.: Analyza mutací genu BRCA1 u skupiny rizikových pacientek s karcinomem ovaria. Medica revue, 2001, 2, s. 44-47.
    • (2001) Medica Revue , vol.2 , pp. 44-47
    • Zikán, M.1    Pohlreich, P.2    Stříbrná, J.3    Jančárková, N.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.